PharmaBoardroom

Interview with Bernhard Sixt, President & CEO, Agendia

Agendia has experienced remarkable growth in the seven years since you founded the company. In 2009 you expanded the company’s Amsterdam facilities…

Interview with Eric Blondeau, Managing Director, Alliance…

You took over this organization just three months ago, having previously headed businesses in industries as diverse as retail, food, and automobiles.…

Interview with Allan Marchington, Partner, Apposite Capital LLP

As a partner at Apposite since the company was created in 2006, what was the founding vision of the company and what do you consider have been its…

Interview with Keith Martin, CEO, Apitope

Apitope’s research and success is based on its High Speed Technology Platform that uses soluble peptides as vehicles to regulate immune responses in…

Interview with Andrew Giddy, CEO, Nucleus Network

Please introduce Nucleus Network and the role it plays in the Australian pharmaceutical sector. Nucleus Network is an early-phase clinical research…

Interview with Rosa Maria Scavarelli, President, Theraskin Brazil

When we met you in 2007, as the head of the former Igefarma, the company was undergoing a transition – from branded generics into dermocosmetics…

Interview with Rogerio MANSUR, Director of Operations, DHL Life…

Rogerio, you were one of the people responsible for integrating two well-established companies in the Brazilian market with the acquisition of Exel by…

Interview with Mark Brown, Head of Tahiland/Vietnam Cluster,…

You are General Manager for Thailand and Vietnam; two markets that certainly interest companies but at a very different stage of development. What are…

Interview with Norbert Oppitz, Senior Vice President Latin…

Big news last year; Takeda bought Nycomed in what has been seen as a game changing acquisition for the pharma world. How have you seen this…

Interview with George Varkanis, Managing Director, Celgene

As a biopharmaceutical company, how have the PBS reforms affected Celgene? Celgene looks at the PBS reforms more positively than negatively. As a…

Interview with Di Ford, Executive Director, Generic Medicines…

To begin, would you please introduce GMIA to Pharmaceutical Executive readers? The GMIA is an industry organization. Its six members are:…

Interview with Mark Glover , Vice President and Managing…

How have PBS reforms impacted Allergan in Australia? The PBS is a very good system that provides Australians with equity of access and has worked well…

Tagged with